Summarized by Masters of Longevity from Neuroscience News.
Dabrafenib reduced brain vascular lesions and leakage in cell and mouse models of cerebral cavernous malformation.

Key Takeaways
- Dabrafenib reduced lesion size and number in mouse models.
- The drug restored cell junctions and reduced vessel leakage.
- Benefit in human patients remains unproven by these preclinical findings.



